211 related articles for article (PubMed ID: 22814256)
1. Atorvastatin and simvastatin, but not pravastatin, up-regulate LPS-induced MMP-9 expression in macrophages by regulating phosphorylation of ERK and CREB.
Lee DK; Park EJ; Kim EK; Jin J; Kim JS; Shin IJ; Kim BY; Lee H; Kim DE
Cell Physiol Biochem; 2012; 30(3):499-511. PubMed ID: 22814256
[TBL] [Abstract][Full Text] [Related]
2. Effects of statins on matrix metalloproteinases and their endogenous inhibitors in human endothelial cells.
Izidoro-Toledo TC; Guimaraes DA; Belo VA; Gerlach RF; Tanus-Santos JE
Naunyn Schmiedebergs Arch Pharmacol; 2011 Jun; 383(6):547-54. PubMed ID: 21448567
[TBL] [Abstract][Full Text] [Related]
3. Redox markers and inflammation are differentially affected by atorvastatin, pravastatin or simvastatin administered before endotoxin-induced acute lung injury.
Melo AC; Valença SS; Gitirana LB; Santos JC; Ribeiro ML; Machado MN; Magalhães CB; Zin WA; Porto LC
Int Immunopharmacol; 2013 Sep; 17(1):57-64. PubMed ID: 23747588
[TBL] [Abstract][Full Text] [Related]
4. Statins inhibit cyclooxygenase-2 and matrix metalloproteinase-9 in human endothelial cells: anti-angiogenic actions possibly contributing to plaque stability.
Massaro M; Zampolli A; Scoditti E; Carluccio MA; Storelli C; Distante A; De Caterina R
Cardiovasc Res; 2010 May; 86(2):311-20. PubMed ID: 19946014
[TBL] [Abstract][Full Text] [Related]
5. Atorvastatin suppresses LPS-induced rapid upregulation of Toll-like receptor 4 and its signaling pathway in endothelial cells.
Wang Y; Zhang MX; Meng X; Liu FQ; Yu GS; Zhang C; Sun T; Wang XP; Li L; Wang YY; Ding SF; Yang JM; Zhang Y
Am J Physiol Heart Circ Physiol; 2011 May; 300(5):H1743-52. PubMed ID: 21317307
[TBL] [Abstract][Full Text] [Related]
6. HMG-CoA reductase inhibitors upregulate heme oxygenase-1 expression in murine RAW264.7 macrophages via ERK, p38 MAPK and protein kinase G pathways.
Chen JC; Huang KC; Lin WW
Cell Signal; 2006 Jan; 18(1):32-9. PubMed ID: 16214041
[TBL] [Abstract][Full Text] [Related]
7. Regulation of macrophage cholesterol efflux through hydroxymethylglutaryl-CoA reductase inhibition: a role for RhoA in ABCA1-mediated cholesterol efflux.
Argmann CA; Edwards JY; Sawyez CG; O'Neil CH; Hegele RA; Pickering JG; Huff MW
J Biol Chem; 2005 Jun; 280(23):22212-21. PubMed ID: 15817453
[TBL] [Abstract][Full Text] [Related]
8. HMG-CoA reductase inhibitors, simvastatin and atorvastatin, downregulate ABCG1-mediated cholesterol efflux in human macrophages.
Wang W; Song W; Wang Y; Chen L; Yan X
J Cardiovasc Pharmacol; 2013 Jul; 62(1):90-8. PubMed ID: 23846804
[TBL] [Abstract][Full Text] [Related]
9. Effects of statins on microglia.
Lindberg C; Crisby M; Winblad B; Schultzberg M
J Neurosci Res; 2005 Oct; 82(1):10-9. PubMed ID: 16118799
[TBL] [Abstract][Full Text] [Related]
10. Effects of atorvastatin and pravastatin on signal transduction related to glucose uptake in 3T3L1 adipocytes.
Takaguri A; Satoh K; Itagaki M; Tokumitsu Y; Ichihara K
J Pharmacol Sci; 2008 May; 107(1):80-9. PubMed ID: 18469500
[TBL] [Abstract][Full Text] [Related]
11. Statins upregulate cystathionine γ-lyase transcription and H2S generation via activating Akt signaling in macrophage.
Xu Y; Du HP; Li J; Xu R; Wang YL; You SJ; Liu H; Wang F; Cao YJ; Liu CF; Hu LF
Pharmacol Res; 2014 Sep; 87():18-25. PubMed ID: 24951966
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms involved in enhancement of matrix metalloproteinase-9 expression in macrophages by interleukin-33.
Ariyoshi W; Okinaga T; Chaweewannakorn W; Akifusa S; Nisihara T
J Cell Physiol; 2017 Dec; 232(12):3481-3495. PubMed ID: 28105703
[TBL] [Abstract][Full Text] [Related]
13. Simvastatin and atorvastatin attenuate VCAM-1 and uPAR expression on human endothelial cells and platelet surface expression of CD40 ligand.
Stach K; Nguyen XD; Lang S; Elmas E; Weiss C; Borggrefe M; Fischer J; Kälsch T
Cardiol J; 2012; 19(1):20-8. PubMed ID: 22298164
[TBL] [Abstract][Full Text] [Related]
14. Statin-induced expression of decay-accelerating factor protects vascular endothelium against complement-mediated injury.
Mason JC; Ahmed Z; Mankoff R; Lidington EA; Ahmad S; Bhatia V; Kinderlerer A; Randi AM; Haskard DO
Circ Res; 2002 Oct; 91(8):696-703. PubMed ID: 12386146
[TBL] [Abstract][Full Text] [Related]
15. Statins (HMG-CoA reductase inhibitors) reduce CD40 expression in human vascular cells.
Mulhaupt F; Matter CM; Kwak BR; Pelli G; Veillard NR; Burger F; Graber P; Lüscher TF; Mach F
Cardiovasc Res; 2003 Sep; 59(3):755-66. PubMed ID: 14499877
[TBL] [Abstract][Full Text] [Related]
16. Simvastatin inhibits induction of matrix metalloproteinase-9 in rat alveolar macrophages exposed to cigarette smoke extract.
Kim SE; Thanh Thuy TT; Lee JH; Ro JY; Bae YA; Kong Y; Ahn JY; Lee DS; Oh YM; Lee SD; Lee YS
Exp Mol Med; 2009 Apr; 41(4):277-87. PubMed ID: 19299917
[TBL] [Abstract][Full Text] [Related]
17. Distinct effects of pravastatin, atorvastatin, and simvastatin on insulin secretion from a beta-cell line, MIN6 cells.
Ishikawa M; Okajima F; Inoue N; Motomura K; Kato T; Takahashi A; Oikawa S; Yamada N; Shimano H
J Atheroscler Thromb; 2006 Dec; 13(6):329-35. PubMed ID: 17192698
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of pravastatin, simvastatin, and atorvastatin on Ca2+ release and vascular reactivity.
Tesfamariam B; Frohlich BH; Gregg RE
J Cardiovasc Pharmacol; 1999 Jul; 34(1):95-101. PubMed ID: 10413074
[TBL] [Abstract][Full Text] [Related]
19. Reduction of platelet cytosolic phospholipase A2 activity by atorvastatin and simvastatin: biochemical regulatory mechanisms.
Moscardó A; Vallés J; Latorre A; Madrid I; Santos MT
Thromb Res; 2013 Apr; 131(4):e154-9. PubMed ID: 23352311
[TBL] [Abstract][Full Text] [Related]
20. Hydroxymethylglutaryl-coenzyme A reductase inhibitors induce apoptosis in human cardiac myocytes in vitro.
Demyanets S; Kaun C; Pfaffenberger S; Hohensinner PJ; Rega G; Pammer J; Maurer G; Huber K; Wojta J
Biochem Pharmacol; 2006 Apr; 71(9):1324-30. PubMed ID: 16540096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
